Pyruvate dehydrogenase deficiency
Pyruvate dehydrogenase deficiency (PDHD) is a rare metabolic disorder that affects the enzyme pyruvate dehydrogenase. This enzyme is crucial for the process of glycolysis, which is the metabolic pathway that converts glucose into pyruvate. In individuals with PDHD, the body is unable to effectively convert glucose into energy, leading to a variety of symptoms and complications.
Symptoms[edit | edit source]
The symptoms of PDHD can vary widely between individuals, but often include neurological problems such as developmental delay, seizures, and ataxia. Other symptoms can include lactic acidosis, hypotonia, and microcephaly. The severity of symptoms can range from mild to severe, and the onset can occur at any age, from infancy to adulthood.
Causes[edit | edit source]
PDHD is caused by mutations in the PDHA1 gene, which provides instructions for making one part of the pyruvate dehydrogenase enzyme. These mutations prevent the enzyme from functioning properly, disrupting the process of glycolysis and leading to a buildup of pyruvate and lactate in the body.
Diagnosis[edit | edit source]
Diagnosis of PDHD is typically made through a combination of clinical examination, genetic testing, and biochemical testing. These tests can identify the presence of the PDHA1 gene mutation and the resulting enzyme deficiency.
Treatment[edit | edit source]
There is currently no cure for PDHD, but treatment can help manage symptoms and improve quality of life. Treatment options may include a high-fat, low-carbohydrate diet known as the ketogenic diet, which can help the body use alternative energy sources. Other treatments may include physical therapy, medications to control seizures, and other supportive therapies.
Prognosis[edit | edit source]
The prognosis for individuals with PDHD can vary widely, depending on the severity of symptoms and the individual's response to treatment. Some individuals may have a normal lifespan with appropriate management, while others may experience severe complications and a shortened lifespan.
See also[edit | edit source]
References[edit | edit source]
| Pyruvate dehydrogenase deficiency Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
